Brian J. Lynch - 16 Jan 2023 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
SVP and General Counsel
Signature
/s/ Brian J. Lynch
Issuer symbol
MDGL
Transactions as of
16 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 19:00:22 UTC
Previous filing
06 Jan 2023
Next filing
01 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Award $0 +15,001 $0.000000 15,001 16 Jan 2023 Direct F1
holding MDGL Common Stock 530 16 Jan 2023 In IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, provided the Reporting Person continues in service with the Issuer on each such date.